Cell Culture Media Development Services

On this page:

Design media to meet process requirements

As cell culture processes mature, standard media may no longer support the specific needs of a given cell line or process. Shifts in productivity, growth performance, or product quality often reflect gaps between the formulation and the execution of the process at scale or under changing conditions. Media development can address this by tailoring formulations to defined process goals using established experimental workflows for cell culture medium development. By aligning media composition with cell line behavior and process requirements, development efforts can support improved performance, consistency, and manufacturability as programs progress.


Flexible workflows tailored to your process goals

Media development can be approached using different workflows depending on process maturity and the level of formulation insight required. Gibco Media by Design Services offers both traditional and multi-omics–guided workflows, allowing teams to select an approach aligned to their timelines, the questions they need to answer, and the current stage of development.

Multi-omics–guided media development

When deeper biological insight is needed, multi-omics workflows extend beyond basic spent media analysis. Proteomic and metabolomic profiling, combined with spent media data and predictive modeling, offers a more comprehensive view of nutrient utilization to inform custom media formulation decisions

Traditional DoE-based media development

For well-characterized processes, standard media development applies iterative Design of Experiments (DoE) approaches supported by spent media analysis. Monitoring key components, including amino acids and water-soluble vitamins, enables controlled optimization of media and feed formulations.

Designed for performance and manufacturing readiness


Effective media development can be achieved when performance and manufacturability are considered together. Formulation design accounts for scalability, raw material sourcing, and format requirements early, so media can transition with the process. Evaluating liquid, dry powder, and granular formats during development helps align with handling, storage, and production needs, so teams can move forward with fewer late-stage changes.

Supporting diverse cell culture modalities

Media development workflows support applications ranging from monoclonal antibodies (mAbs) and recombinant proteins to vaccines, cell therapy, and gene therapy processes, each with distinct cell types and culture formats. Adapting media design to these modality-specific requirements supports consistent upstream process (USP) performance across varied process environments.

Engage with media development teams


Full-service projects are conducted at global Gibco facilities, where formulation design, cell culture studies, and analysis are managed. Consultative engagements on customer-run experiments support study design, media formulation, and data interpretation. These options allow teams to engage at a level that aligns with available resources, internal experience, and program timelines.


Frequently asked questions

Media development is typically considered when screening, panel evaluations, or incremental optimization no longer supports defined process goals. Common decision points include stalled productivity gains, emerging product quality concerns, or constraints introduced as processes move toward scale-up. Media development may also be appropriate when preparing for manufacturing, establishing platform processes, or when greater control over consistency and performance is required as programs advance.

Media development incorporates manufacturing considerations early in the formulation design. Factors, such as scalability, raw material availability, formulation complexity, and format requirements, are evaluated alongside performance. Liquid, dry powder, and granular formats are assessed to align with handling, storage, and production workflows, supporting continuity as processes transition from non-cGMP development to cGMP manufacturing.

Traditional DoE-based workflows are often suitable when processes are well characterized, and targeted optimization is required. Multi-omics workflows may be appropriate when performance limitations are not well understood, when multiple variables appear to be interacting, or when deeper biological insight is needed to inform formulation decisions. Timelines and the nature of performance challenges, such as a hard-to-express molecule or high expression requirements, also are considerations.

Full-service media development projects are performed at Gibco facilities, where formulation design, cell culture experimentation, and data analysis are conducted by dedicated development teams. Consultative projects support customer-run experiments, with Gibco scientists offering help with experimental design, media formulation, and data interpretation. These engagement models allow teams to align project execution with internal resources and capabilities.

Media development helps in identifying components and attributes that influence performance or product quality. Optimized formulations can be advanced into rapid prototyping to evaluate manufacturability, format conversion, and scale behavior. Together, these activities support a structured transition into scalable cGMP manufacturing while maintaining alignment with upstream process requirements.

Media development is part of a broader set of upstream services designed to support process understanding and progression. Gibco Media by Design Services also includes analytics and screening capabilities that extend insight beyond formulation design.

Bioprocess analytics

Interpreting changes in cell growth, productivity, or product quality requires visibility into how media components are being utilized. Bioprocess analytics examine these relationships directly, connecting formulation composition with cell and product-level responses.

Media and feed screenings

Instead of adjusting formulations in isolation, media and feed screening enables early comparison across a range of nutritionally distinct options. Evaluating multiple formulations under the same conditions highlights relative performance differences and helps select target leads quickly.

Bioprocessing resources

Access a set of articles, case studies, brochures, and multimedia content that explore media development approaches and upstream workflow considerations in greater detail.

For research use or further manufacturing. Not for diagnostic use or direct administration into humans or animals.